...
首页> 外文期刊>DNA and Cell Biology >Investigation of BRAF V600E Mutation in Papillary Thyroid Carcinoma and Tumor-Surrounding Nontumoral Tissues
【24h】

Investigation of BRAF V600E Mutation in Papillary Thyroid Carcinoma and Tumor-Surrounding Nontumoral Tissues

机译:乳头状甲状腺癌和肿瘤周围非肿瘤组织中BRAF V600E突变的研究

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to investigate the association between the BRAF V600E mutation incidence and histopathologic prognostic risk factors for papillary thyroid carcinoma (PTC) on the Turkish population. The contribution of BRAF V600E mutation in both tumor and tumor-surrounding nontumoral tissues of 108 patients with PTC was assessed using mutant allele-specific amplification-polymerase chain reaction. The BRAF V600E mutation was found in 52.8% of the tumor tissues, and 7.4% of the tumor-surrounding nontumoral tissues. The BRAF V600E mutation was significantly higher in the tumor tissues of the classic variant of PTC (CVPTC) cases than the follicular variant of PTC cases (p = 0.001). The presence of the BRAF V600E mutation was more frequent in women, but this gender difference was not statistically significant. BRAF V600E mutation was more frequent in patients with either one of adenomatous hyperplasia or diffuse hyperplasia in tumor-surrounding nontumoral tissues (p = 0.012). There was no significant difference in the BRAF V600E mutation distribution among tumor-surrounding nontumoral tissues of the two P
机译:这项研究的目的是调查BRAF V600E突变发生率与土耳其人群乳头状甲状腺癌(PTC)的组织病理学预后危险因素之间的关系。使用突变体等位基因特异性扩增-聚合酶链反应评估BRAF V600E突变在108例PTC患者的肿瘤和肿瘤周围非肿瘤组织中的作用。在52.8%的肿瘤组织和7.4%的围绕肿瘤的非肿瘤组织中发现了BRAF V600E突变。在PTC经典病例(CVPTC)病例的肿瘤组织中,BRAF V600E突变明显高于PTC病例的卵泡变异(p = 0.001)。妇女中BRAF V600E突变的发生率更高,但是这种性别差异在统计学上并不显着。在围绕肿瘤的非肿瘤组织中,患有腺瘤样增生或弥漫性增生之一的患者,BRAF V600E突变更为频繁(p = 0.012)。在两个P周围的非肿瘤组织之间,BRAF V600E突变分布没有显着差异

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号